A1D5U

methyl (2~{R})-2-phenyl-2-[(2~{R})-piperidin-2-yl]ethanoate

Find entries where: A1D5U

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	methyl (2~{R})-2-phenyl-2-[(2~{R})-piperidin-2-yl]ethanoate
Synonyms	Dexmethylphenidate
Identifiers	methyl (2~{R})-2-phenyl-2-[(2~{R})-piperidin-2-yl]ethanoate
Formula	C₁₄ H₁₉ N O₂
Molecular Weight	233.306
Type	NON-POLYMER
Isomeric SMILES	COC(=O)[C@H](c1ccccc1)[C@H]2CCCCN2
InChI	InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1
InChIKey	DUGOZIWVEXMGBE-CHWSQXEVSA-N

Chemical Details
Formal Charge	0
Atom Count	36
Chiral Atom Count	2
Bond Count	37
Aromatic Bond Count	6

Drug Info: DrugBank

DrugBank ID	DB06701
Name	Dexmethylphenidate
Groups	investigational approved
Description	Dexmethylphenidate is the dextrorotary form of methylphenidate introduced in 2002[A177181]. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and thus a psychostimulant[A177193]. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD)[Label,A177181]. The d-isomer is thought to have greater effect with fewer side effects than the l-isomer or the racemic mixture[A177181].
Synonyms	d-threo-methylphenidate D-TMP Dexmetilfenidato Dexmethylphenidate Dexmethylphenidate hydrochloride Dexmethylphenidatum (+)-threo-methylphenidate Dexméthylphénidate methyl (R)-phenyl[(R)-piperidin-2-yl]acetate
Brand Names	Dexmethylphenidate Hydrochloride Focalin XR Attenade Dexmethylphenidate Hydrochloride Extended-Release Dexmethylphenidate HCl Dexmethylphenidate hydrochloride FocalinXR Azstarys Focalin
Indication	Dexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment[A177187,Label].
Categories	Agents that produce hypertension Antidepressive Agents Central Nervous System Agents Central Nervous System Depressants Central Nervous System Stimulants Central Nervous System Stimulation Centrally Acting Sympathomimetics Combined Inhibitors of Serotonin/Norepinephrine Reuptake Dopamine Agents Dopamine Uptake Inhibitors Membrane Transport Modulators Methylphenidate and isomer Nervous System Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Phenylacetates Piperidines Psychoanaleptics Psychostimulants, Agents Used for ADHD and Nootropics Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin Agents Serotonin Modulators
ATC-Code	N06BA11 N06BA15
CAS number	40431-64-9

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Sodium-dependent dopamine transporter	MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNP...	unknown	inhibitor
Sodium-dependent noradrenaline transporter	MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRD...	unknown	inhibitor
Sodium-dependent serotonin transporter	METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAV...	unknown	inhibitor
Carboxylesterase	APPPVPKTPAGPLTLSGQGSFFVGGRDVTSETLSLSPKYDAHGTVTVDQM...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

A1D5U

methyl (2~{R})-2-phenyl-2-[(2~{R})-piperidin-2-yl]ethanoate

Chemical Component Summary

Chemical Details

Drug Info: DrugBank

Drug Targets